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Background: Previously we described a transdominant negative mutant of the HIV-1 Tat protein, termed Nullbasic,
that downregulated the steady state levels of unspliced and singly spliced viral mRNA, an activity caused by inhibition
of HIV-1 Rev activity. Nullbasic also altered the subcellular localizations of Rev and other cellular proteins, including
CRM1, B23 and C23 in a Rev-dependent manner, suggesting that Nullbasic may disrupt Rev function and trafficking by
intervening with an unidentified component of the Rev nucleocytoplasmic transport complex.
Results: To seek a possible mechanism that could explain how Nullbasic inhibits Rev activity, we used a proteomics
approach to identify host cellular proteins that interact with Nullbasic. Forty-six Nullbasic-binding proteins were
identified by mass spectrometry including the DEAD-box RNA helicase, DDX1. To determine the effect of DDX1
on Nullbasic-mediated Rev activity, we performed cell-based immunoprecipitation assays, Rev reporter assays and
bio-layer interferometry (BLI) assays. Interaction between DDX1 and Nullbasic was observed by co-immunoprecipitation
of Nullbasic with endogenous DDX1 from cell lysates. BLI assays showed a direct interaction between Nullbasic and
DDX1. Nullbasic affected DDX1 subcellular distribution in a Rev-independent manner. Interestingly overexpression of
DDX1 in cells not only restored Rev-dependent mRNA export and gene expression in a Rev reporter assay but also
partly reversed Nullbasic-induced Rev subcellular mislocalization. Moreover, HIV-1 wild type Tat co-immunoprecipitated
with DDX1 and overexpression of Tat could rescue the unspliced viral mRNA levels inhibited by Nullbasic in HIV-1
expressing cells.
Conclusions: Nullbasic was used to further define the complex mechanisms involved in the Rev-dependent nuclear
export of the 9 kb and 4 kb viral RNAs. All together, these data indicate that DDX1 can be sequestered by Nullbasic
leading to destabilization of the Rev nucleocytoplasmic transport complex and decreased levels of Rev-dependent
viral transcripts. The outcomes support a role for DDX1 in maintenance of a Rev nuclear complex that transports
viral RRE-containing mRNA to the cytoplasm. To our knowledge Nullbasic is the first anti-HIV protein that specifically
targets the cellular protein DDX1 to block Rev’s activity. Furthermore, our research raises the possibility that wild
type Tat may play a previously unrecognized but very important role in Rev function.
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The human immunodeficiency virus type-1 (HIV-1) Rev
trans-activator is required for virus replication. It is
expressed from the multiply spliced (~2 Kb) viral tran-
script and mediates the expression of viral structural,
enzymatic and accessory proteins from the unspliced
(~9 Kb) and singly spliced (~4 Kb) viral transcripts [1].
Rev is a 116 amino acid protein and can be divided into
three discrete function domains. The Rev RNA-binding
domain (RBD, amino acids 35–51) is an arginine-rich
motif that serves as the nucleolar localization signal
(NLS), which can be recognized by the cellular importin
β-like import receptors and nucleophosmin (NPM), also
known as B23 [2-5]. This region also specifically inter-
acts with a stem loop RNA sequence called Rev response
element (RRE), which is located within the env gene
among unspliced and singly spliced HIV-1 mRNAs [6,7].
The activation domain (amino acid 77–83) is a leucine-
rich motif that acts as a nuclear export signal (NES) that
directly interacts with cellular chromosome region main-
tenance 1(CRM1), also known as exportin 1 (XPO1),
in the presence of RanGTP [8-11]. Regions flanking
the RBD constitute the multimerization domain (amino
acids 12–33 and 51–60). It has been demonstrated that
formation of the HIV-1 Rev:RRE protein complex [also
called Rev ribonucleoprotein (RNP) complex] requires
the recruitment of multiple Rev monomers [12-14]. Since
Rev contains both NLS and NES, it acts as a shuttling
protein that constantly traffics between the nucleus and
the cytoplasm. In HIV-1 infected cells, Rev binds to
unspliced and singly spliced HIV-1 mRNAs via their RRE
to form a Rev RNP complex with CRM1 and other cellu-
lar components in the nucleolus, then CRM1 directs the
whole complex through the nuclear pore to the cyto-
plasm [10,15,16]. The Rev RNP complex is disassembled
in the cytoplasm, allowing translation to begin. Cytoplas-
mic Rev is then recognized by the importin β-like import
receptors, such as importin β and transportin 1, and trans-
ported back to the nucleus [3,5,17]. Once Rev enters the
nucleus, B23 binds to Rev’s NLS in the RBD and facilitates
import of Rev to the nucleolus for reformation of the Rev
RNP complex [4]. In addition to Rev’s major function in
promoting nuclear export of incompletely spliced viral
transcripts, other activities in integration, translation and
encapsidation have been described [18-20].
DEAD (Asp - Glu - Ala - Asp)-box helicases form the
largest family of RNA helicases and are conserved in
bacteria, archaea and eukaryotes [21]. They are associ-
ated with many levels of RNA function including tran-
scription, pre-mRNA splicing, ribosome biogenesis, RNA
trafficking, RNA decay and translation initiation [22,23].
Although HIV-1 does not encode for an RNA heli-
case, a number of cellular DEAD-box RNA helicases,
including DDX1, DDX3, DDX5/p68, DDX17, DDX21,DDX24, DDX36, DDX47 and DDX56, have been identified
to play crucial roles in the HIV-1 replication cycle, par-
ticularly in the regulation of Rev function [24]. DDX1 dir-
ectly interacts with the multimerization domain of HIV-1
Rev protein to promote Rev oligomerization on the RRE
[25]. Overexpression of DDX1 in HIV-1 infected cells re-
sults in increased virus production, while downregulation
of DDX1 by RNAi not only inhibits viral replication but
also unexpectedly alters the subcellular localization of Rev
from predominantly nucleolus to nucleus and cytoplasm,
resulting in inhibition of nuclear export of incompletely
spliced viral mRNAs [26,27]. Of note, low DDX1 levels in
primary human astrocytes have effects on Rev subcellular
localization similar to DDX1 RNAi [28]. Similar to DDX1,
DDX3, known as a nucleocytoplasmic shuttle protein, dir-
ectly binds to CRM1 and mediates Rev-dependent viral
mRNA transport [29]. Knockdown of endogenous DDX3
using short hairpin RNA (shRNA) or expression of DDX3
transdominant-negative mutant protein suppresses nu-
clear export of incompletely spliced HIV-1 mRNAs and
viral replication [29,30]. In addition to modulation of Rev
function, DDX3 was reported to directly interact with the
HIV-1 Tat protein to facilitate Tat function and HIV-1
mRNA translation [31,32]. Recent studies further indicate
that DDX5, DDX17, DDX21, DDX24, DDX36, DDX47 and
DDX56 all associate with the HIV-1 Rev protein and co-
operate to regulate Rev function [33,34].
Our previous studies described a two-exon HIV-1 Tat
mutant termed Nullbasic, created by replacing the entire
basic domain of wild-type Tat with glycine and alanine
residues, which provides strong protection from HIV-1
infection by potently inhibiting multiple steps of the
HIV-1 replication cycle [35]. Nullbasic has at least three
anti-HIV-1 activities. It inhibits Tat-mediated transacti-
vation activity, suppresses HIV-1 reverse transcription
and reduces steady state levels of unspliced and singly-
spliced viral mRNA by the inhibition of Rev activity
[35,36]. With respect to Rev, Nullbasic also alters its
subcellular localization as well as the subcellular locali-
zations of cellular proteins including CRM1, B23 and
C23 in a Rev-dependent manner, suggesting that Nullbasic
interferes with a component of the Rev nucleocytoplasmic
transport complex required for Rev trafficking and func-
tion [35,37]. Here we employed a proteomics approach to
identify cellular proteins that interact with Nullbasic. Co-
immunoprecipitation assays identified 46 host protein
candidates across independent mass spectrometry analyses,
including three DEAD-box RNA helicases, DDX1, DDX3
and DDX17. We found that DDX1 interacts with Nullbasic
directly leading to the disruption of Rev subcellular
localization and resulting in decreased levels of incom-
pletely spliced viral transcripts. Thus, our study provides
further evidence of an important role for DDX1 in the
maintenance of Rev subcellular localization and function.
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type Tat also associated with DDX1 and overexpression of
Tat in cells could restore Rev mediated export of viral
mRNA that had been inhibited by Nullbasic, implying a
novel and previously unrecognized function for wild type
Tat to support Rev function.
Results
Identification of Nullbasic interacting proteins by LC
MS/MS
In this study, we focused on nuclear Nullbasic interac-














































Figure 1 Proteomic strategy for identifying Nullbasic-interacting prot
proteomic approach for isolating Nullbasic (NB) binding proteins from cell
and an overview of the methods used to generate lentiviral VLPs. pCM
pLOX/CW-FLAG-mCherry were co-transfected into HEK293T cells to produce
(VLP-NB-mCherry) or the control FLAG-mCherry genome (VLP-FLAG-mCherr
HeLa cells in order to create cell lines stably expressing either the NB-mC
expressing NB-mCherry or FLAG-mCherry were separated by SDS-PAGE andisrupted the nucleolar colocalization of HIV-1 Rev with
CRM1, B23 and C23 but did not affect importin β- and
transportin 1-mediated Rev nuclear import pathways
[37], suggesting that Nullbasic interferes with specific
components of a Rev nuclear complex. The experimen-
tal strategy used to identify protein complexes associated
with Nullbasic is illustrated in Figure 1A. HeLa cells
were transduced with lentiviral vectors that could express
either Nullbasic-FLAG-mCherry or FLAG-mCherry pro-
tein. For each transduction, mCherry positive cells were
collected by FACS and HeLa stable cell lines expressing














































eins from HeLa-Nullbasic-mCherry cells. A. Overview of the
nuclear extracts. B. Schematic diagrams of the VLP expression plasmids
VΔR8.91, pCMV-VSV-G and pLOX/CW-Nullbasic-FLAG-mCherry or
VLPs containing either Nullbasic-FLAG-mCherry lentivector genome
y). VLP-NB-mCherry and VLP-FLAG-mCherry were then transduced into
herry proteins or FLAG-mCherry proteins. C. Nuclear protein lysates
d protein bands were stained with Coomassie dye.
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analyzed by western blotting [see Additional file 1].
Nuclear Nullbasic-FLAG-mCherry and FLAG-mCherry
interacting protein complexes were immunoprecipi-
tated using anti-FLAG beads. Following extensive washes,
immunoprecipitated protein complexes were eluted, sepa-
rated by SDS-PAGE and stained with Coomassie dye
(Figure 1C). Protein bands were sliced, digested with tryp-
sin and analysed by LC MS/MS. Protein identification was
performed with ProteinPilot 4.0 software (AB SCIEX)
against the UniProt database restricted to Homo sapiens.
Proteins were considered “identified” if more than two
peptides identified with a >95% confidence and a < 1% glo-
bal false discovery rate (FDR). A total of 379 proteins were
detected from the NB-FLAG-mCherry nuclear fractions,
of which 333 were only detected in a single experiment or
detected in the control immunoprecipitations and there-
fore excluded as “significant”. In the final analysis, 46 pro-
teins were considered “significant” as they were detected
at least twice across three independent experiments [see
Additional file 2]. These 46 identified proteins could be
classified into 6 broad functional groups: RNA splicing/
transport factors, folding/transport proteins, transcription
regulators, translation factors, cellular organization/
cytoskeleton and cell cycle. Of immediate interest were the
DEAD-box RNA helicases DDX1, DDX3 and DDX17 since
all of these were identified in each experiment, and associ-
ate with HIV-1 Rev and regulate its function.
To validate the interactions of Nullbasic with DDX1,
DDX3 and DDX17, co-immunoprecipitation experiments
were performed using HEK293T cells expressing FLAG-
tagged Nullbasic (Nullbasic-FLAG) (Figure 2). Immuno-
precipitation of Nullbasic-FLAG with anti-FLAG beads
did co-immunoprecipitate endogenous DDX1, DDX3 and
DDX17 as well as CDK9. The interaction of Nullbasic and






























Figure 2 Interactions of DDX1, DDX3 and DDX17 with Nullbasic in vivo.
plasmid expressing NB-FLAG. The FLAG-tagged proteins and their binding pa
immunoprecipated proteins were separated by SDS-PAGE and target proteins
antibodies. The anti-CDK9 antibody was used to detect endogenous CDK9 as
independent experiments.positive control. An empty vector (pcDNA 3.1) transfec-
tion was included as a negative control. These data con-
firmed that Nullbasic is able to interact with DDX1,
DDX3 and DDX17.
Nullbasic inhibition of Rev/RRE-dependent mRNA export
can be counteracted by overexpression of DDX1
We previously showed that Nullbasic downregulated
Rev function and Rev-dependent viral mRNA steady
state levels [35]. To test whether this inhibitory effect is
due to the interaction of DDX1, DDX3 or DDX17 with
Nullbasic, we analyzed translation of Rev-dependent
viral mRNA by utilizing pGag-RRE and pGag-CTE re-
porter plasmids (Figure 3A). Both plasmids are cyto-
megalovirus (CMV) immediate-early promoter-driven
Gag/protease (PR) vectors [38]. The pGag-RRE plasmid
contains the RRE that can produce HIV-1 Gag and PR
proteins in a Rev-dependent manner, while pGag-CTE
plasmid contains 4 copies of the constitutive transport
element (CTE) of Mason-Pfizer monkey virus that ex-
press Gag and PR proteins in a Rev-independent man-
ner. The Gag-derived proteolytic product capsid (CA)
protein was measured in cell lysates by ELISA. As ex-
pected, the expression of Rev alone with pGag-RRE pro-
duced measurable CA compared to CA expression by
pGag-RRE without Rev (Figure 3B, left, lanes 1 and 13).
Expression of Nullbasic, HA-tagged DDX1 (HA-DDX1),
HA-tagged DDX3 (HA-DDX3), and HA-tagged DDX17
(HA-DDX17) and parental vector (pcDNA3-HA) alone
in the Rev-dependent reporter assay observed no or low
expression of CA protein (Figure 3B, left, lane 2, 4, 7, 10
and 13). The levels of CA were greatly increased when
Rev was coexpressed with HA-DDX3 (Figure 3B, left,
lane 8) or HA-DDX17 (Figure 3B, left, lane 11) in the
Rev-dependent reporter assay compared to expression of






























HEK293T cells were transfected with either empty vector (pcDNA 3.1) or
rtners were immunoprecipated with anti-FLAG beads. Total cell lystes and
were detected using anit-FLAG, anti-DDX1, anti-DDX3 and anti-DDX17













































































































































1    2     3     4     5     6     7     8      9    10   11   12   13
Figure 3 Overexpression of DDX1 in HeLa cells rescues the Rev/RRE-dependent reporter gene expression suppressed by Nullbasic.
A. Schematic maps of pGag-RRE and pGag-CTE plasmids. B. Left: HeLa cells were transfected with appropriate expression plasmids, including
pGag-RRE (500 ng), pRSV-Rev (10 ng), Nullbasic (NB, 500 ng), HA-DDX1(1000 ng), HA-DDX3 (1000 ng), DDX17 (1000 ng) and empty plasmid
(pcDNA3-HA, 1000 g). Right: HeLa cells were transfected pGag-CTE (500 ng) with pRSV-Rev (10 ng), Nullbasic (NB) (500 ng), HA-DDX1(1000 ng) or
empty vector (pcDNA3-HA, 1000 ng). A pcDNA3 plasmid was used to normalize the total amount of transfected plasmids and a luciferase expression
plasmid was included to monitor transfection efficiency. After 24 h transfection, the cellular lysates were collected for assay of HIV-1 capsid level and
luciferase activity. The p24 production was normalized to the luciferase reporter activity and expressed as a percentage relative to cells transfected with
pGag-RRE with pRSV-Rev (left) or pGag-CTE with pRSV-Rev (right). Columns represent the means and standard deviations of transfections performed in
triplicate. The experiment was performed 3 times with similar results.
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of Rev with HA-DDX1 (Figure 3B, left, lane 5) reduced
CA expression ~ 25% (p = 0.02) compared to expression
of Rev alone (Figure 3B, left, lane 1). However, coexpres-
sion of Rev and Nullbasic in the Rev-dependent reporter
assay resulted in a ~ 80% decrease (p = 0.0004) of CA ex-
pression (Figure 3B, left, lane 3) compared to expression
of Rev alone (Figure 3B, left, lane 1). This result con-
firmed our previous studies that Nullbasic can interfere
with Rev function, leading to loss of Rev-mediated viral
gene expression [35]. Quite surprisingly, Nullbasic did
not alter CA expression when HA-DDX1 was expressed
in the cells co-expressing Rev and Nullbasic (Figure 3B,
left, comparison of lane 5 and 6). In contrast, the levels ofCA were decreased 20% (p = 0.00005) and 30% (p = 0.009)
in the reporter assay coexpressing Nullbasic, Rev and HA-
DDX3 (Figure 3B, left, lane 9) or HA-DDX17 (Figure 3B,
left, lane 12) compared to coexpression of Rev and HA-
DDX3 (Figure 3B, left, lane 8) or HA-DDX17 (Figure 3B,
left, lane 11). Expression of Rev, Nullbasic, HA-DDX1and
parental vector (pcDNA3-HA) had no effect on CA ex-
pression from pGag-CTE (Figure 3B, right). We conclude
that overexpression of DDX1 can compensate for the in-
hibitory effect of Nullbasic on Rev function.
Nullbasic affects the subcellular distribution of DDX1
Our previous studies observed that Nullbasic redistrib-
utes not only Rev’s subcellular localization within the
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plasm but also certain cellular proteins, including CRM1,
B23 and C23, in a Rev-dependent manner [37]. To investi-
gate whether alteration of Rev subcellular localization in-
duced by Nullbasic also affects the subcellular distributions
of DDX1, we visualized its subcellular localization in HeLa
cells using fluorescence microscopy. In cells transfected
with parental pcDNA3.1 plasmid, endogenous DDX1 was
primarily found in the nucleus (Figure 4A, row 1), as ob-
served by others [28]. As expected, the localization of































































Figure 4 Nullbasic alters the subcellular localization of DDX1. A. HeLa
MYC-Rev alone (row 2), Nullbasic (NB)-mCherry alone (row 3 a) or MYC-Rev
anti-MYC (green) and anti-DDX1 (magenta, upper panels) and were visualiz
were stained with DAPI. The overlay panels show the merge of the Rev pa
panel (row 3). Images are representative of at least five fields selected r
nuclear/cytoplasmic fluorescence ratios(Fn/c) for DDX1as described in M
3 independent experiments.(Figure 4A, row 2). Interestingly, we observed a sig-
nificant amount of DDX1 relocalized to the cytoplasm
when HeLa cells expressed Nullbasic-mCherry either
alone (Figure 4A, row 3) or with MYC-Rev (Figure 4A,
row 4). To quantify the extent of cytoplasmic redistri-
bution of DDX1 within the cells expressing Nullbasic,
we measured the nuclear/cytoplasmic fluorescence ratio
(Fn/c). The result showed that Nullbasic significantly
(p < 0.0005) enriched the level of DDX1 in the cyto-
plasm compared with in its absence (Figure 4B). Ex-










cells were transfected with empty vector alone (pcDNA3.1, row 1),
with NB-mCherry (row 4). Fixed cells were immunostained with
ed alone with NB-mCherry (red) by fluorescence microscopy. Nuclei
nel with DDX1 (row 1, 2, and 4) and the NB-mCherry panel with DDX1
andomly from three independent experiments. B. Quantification of
ethods. Mean of Fn/c ± SD were calculated from 60 HeLa cells from
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effect on DDX3 and DDX17 subcellular distribution
[see Additional file 3]. As previous observed [35,37],
coexpression of Nullbasic-mCherry with MYC -Rev in-
duced Rev mislocalization from the nucleolus to the
nucleoplasm and cytoplasm (Figure 4A, row 4). These data
thus show that Nullbasic associates with DDX1 leading to
the alteration of DDX1 subcellular distribution.
Overexpression of DDX1 rescues Nullbasic-induced Rev
subcellular mislocalization
Next, we monitored subcellular distributions of MYC-
Rev and Nullbasic-mCherry in HeLa cells where DDX1
was overexpressed. We observed that HA-DDX1 was
predominantly in the nucleus but some cytoplasmic
HA-DDX1 was also detected in the presence or absence
of MYC-Rev (Figure 5, row 1 and 2). Expression of
Nullbasic-mCherry either alone or with MYC-Rev in-
duced uniform redistribution of HA-DDX1 from the nu-
cleus throughout the entire cell (Figure 5, row 3 and 4).
Surprisingly, coexpression of HA-DDX1 with Nullbasic-
mCherry resulted in the absence of MYC-Rev in the
cytoplasm and its accumulation in the nucleus (Figure 5,
row 4), indicating that mislocalization of MYC-Rev to

























































Figure 5 Overexpression of DDX1 in HeLa cells restores Rev nucleola
with HA-DDX1 alone (row 1), MYC-Rev with HA-DDX1 (row 2). Nullbasic (N
NB-mCherry (row 4). Fixed cells were immunostained with anti-MYC (green
NB-mCherry (red) by fluorescence microscopy. Nuclei were stained with DA
HA-DDX1 panels (row 1, 2, and 4) and the NB-mCherry panel with HA-DDX
randomly from three independent experiments.reversed by overexpression of HA-DDX1. Thus, these
experiments imply that Nullbasic disrupts a role of
DDX1 in maintaining the subcellular distribution of
Rev.
Nullbasic directly binds to DDX1 in vitro
Based on the above results, we hypothesized that the
RNA helicase DDX1 binds to Nullbasic directly. To test
the hypothesis, an in vitro binding assay based on Bio-
Layer Interferometry (BLI) [40,41] was performed to
study the interaction between DDX1 and Nullbasic. Bio-
tinylated recombinant Nullbasic-FLAG-V5-6 × His was
immobilized on streptavidin-coated biosensors and incu-
bated with highly purified Myc-DDK-tagged DDX1 ob-
tained from HEK 293 T cells at concentrations ranging
from 3.3 to 90 nM. Bovine serum albumin (BSA) was
used as a negative control. As predicted, recombinant
Nullbasic could directly bind to recombinant DDX1 with
a dissociation constant (KD) value of ~6 nM under the
conditions tested, whereas no direct binding was ob-
served between BSA and Nullbasic-FLAG-V5-6 × His
(Figure 6A). A second negative control used purified
Myc-DDK-tagged DDX5 under the same experimen-
tal conditions. The assay showed that DDX5 did not
bind to Nullbasic-FLAG-V5-6 ×His, even at the highestDAPI OverlayHA-DDX1
r localization disrupted by Nullbasic. HeLa cells were transfected
B)-mCherry with HA-DDX1 (row 3) or MYC-Rev with HA-DDX1 and
) and anti-HA (magenta) antibodies and were visualized alone with
PI. The overlay panels show the merge of the MYC-Rev panel with the






NB DDX1 (10 nM)
NB DDX1 (3.3 nM)
Signal Probe Solution
NB DDX5 (90 nM)
NB DDX5 (30 nM)
NB DDX5 (10 nM)
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Association Dissociation



























NB BSA (90 nM)
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Figure 6 DDX1 directly interacts with Nullbasic in vitro. The Octet Red system was used to measure binding events between Nullbasic and
DDX1. A. BLI sensograms. Biotinylated recombinant Nullbasic-FLAG-V5-6 × His was bound to a streptavidin biosensor and applied to solutions
containing 3.3 nM (green), 10 nM (light blue), 30 nM (red) or 90 nM (dark blue) of human recombinant Myc-DDK-tagged DDX1. B. The probe was
also exposed to DDX5 solutions of the same concentration or with BSA at 90 nM as negative controls. The BLI experiment was repeated 3 times
with similar results and a representative sensogram is shown.
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cated that Nullbasic can directly interact with DDX1
in vitro.
DDX1 forms different protein complexes with Nullbasic
and Rev in cells
Since Nullbasic is able to bind DDX1 directly in vitro,
co-immunoprecipitation experiments were further under-
taken to examine whether Nullbasic can compete with
Rev for binding to DDX1. HIV-1 Rev and Nullbasic-
FLAG proteins were expressed in HEK293T cells by
plasmid transfection either alone or together (Figure 7).
After 24 h transfection, cell lysates were used for co-
immunoprecipitation experiments. Endogenous DDX1
and Nullbasic proteins were immunoprecipitated with
anti-DDX1 and anti-FLAG antibody-coated beads separ-
ately. We observed DDX1 co-immunoprecipitated both
Rev and Nullbasic, suggesting DDX1 is able to interact
with both proteins. However, immunoprecipitation of
Nullbasic did not co-immunoprecipitate Rev, as previously
reported [37], but did co-immunoprecipitate endogenousDDX1, suggesting that Nullbasic can bind to DDX1 and
may form a Nullbasic:DDX1 complex with limited capacity
to interact with Rev.
Previous studies have reported that HIV-1 Tat inter-
acted with DDX3, DDX5, DDX18, DDX19, DDX21 and
DDX24. However, the interaction between Tat and DDX1
has not been reported. Here, we found that DDX1 associ-
ated with HIV-1 Tat in reciprocal immunoprecipitations
using either an anti-DDX1 or anti-FLAG as the capture
antibody (Figure 7B). These results indicate that the inter-
action between Nullbasic and DDX1 is not through Tat’s
basic domain and Nullbasic can compete with Rev for
binding to DDX1.
Nullbasic inhibition of Rev activity can be counteracted
by overexpression of wild type Tat
We previously showed that coexpression of Nullbasic
with HIV-1 in producer cells resulted in the reduced
steady-state levels of singly-spliced and unspliced viral
mRNA [35]. We hypothesize that Nullbasic may act in a

















































































































Figure 7 DDX1 forms different protein complexes with Nullbasic and Rev. A. HEK293T cells were transfected with either empty vector
(pcDNA 3.1) alone, Nullbasic (NB)-FLAG alone, Rev alone or co-transfect NB-FLAG with Rev as indicated. Endogenous DDX1, NB-FLAG and their
binding partners were immunoprecipated with anti-DDX1 and anti-FLAG beads. Cell lystes and immunoprecipated proteins were separated by
SDS-PAGE and target proteins were detected using anti-FLAG, anti-DDX1 and anti-Rev antibodies. B. HEK293T cells were transfected with empty
vector or Tat-FLAG as indicated. Target proteins were detected using anti-FLAG, anti-DDX1 after immunoprecipitation using anti-DDX1, anti-FLAG
beads or with beads alone. The figures are representative of 3 independent experiments.
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pothesis, we used a recombinant infectious HIV-1 pro-
viral construct, pGCH, in which the cytomegalovirus
(CMV) immediate-early promoter replaces the HIV-1 5′
U3 region but retained the natural HIV-1 transcriptional
start site in the R region [35]. The pGCH plasmid ex-
presses all accessory and regulatory genes including Tat
and Rev. Importantly, RNA polymerase II-directed tran-
scription from the CMV promoter in this construct is
only minimally affected by Tat and Nullbasic, thereby
allowing the segregation of Tat’s role in transactivation
from other potential biological roles in the virus life
cycle [35]. As shown in Figure 8, HEK293T cells cotrans-
fected with pGCH and a plasmid encoding Nullbasic-
FLAG had significantly reduced (p = 0.02) amounts of
unspliced viral mRNA relative to total viral mRNA
when compared to cells transfected with pGCH alone
(Figure 8). Significantly, coexpression of wild type Tat
with Nullbasic restored the steady state levels of unsplicedviral mRNA (p = 0.0005, compared to cells contransfected
with pGCH and Nullbasic), suggesting that Tat compen-
sated for the inhibitory effect of Nullbasic on Rev function.
Discussion
As a general rule, unspliced or incompletely spliced cellu-
lar mRNA transcripts, as well as HIV-1 mRNA tran-
scripts that encode many HIV-1 structural and regulatory
proteins, are retained in the nucleus and degraded. Ex-
tensive research has identified cellular proteins by direct
and indirect interactions with Rev that facilitate trans-
port of RRE-containing viral mRNA out of the nucleus
[34,42-44]. We had shown that a mutant Tat protein, we
call Nullbasic, has an intriguing ability to inhibit Rev func-
tion resulting from its mislocalization from the nucleolus
to the nucleoplasm and cytoplasm. We hypothesized that
Nullbasic targeted and perhaps sequestered a cellular pro-
tein, rather than directly targeting Rev as studies have












































Figure 8 Overexpression of wild type Tat rescues the unspliced viral mRNA levels suppressed by Nullbasic in HIV-1 expressing cells.
Total RNA was extracted from HEK293T cells transfected to express the HIV-1 infectious provirus, pGCH, and co-transfected at a 1:2 molar ratio
with either empty vector (“No Tat”) or plasmids expressing Nullbasic-FLAG (“NB”), Tat-FLAG (“Tat”), or Nullbasic-FLAG with Tat-FLAG (“NB + Tat”).
The levels of total (black columns) and unspliced (gray columns) HIV-1 mRNAs were assayed by quantitative RT-PCR using primers specific for total
and unspliced viral mRNA. Results represent the means and standard deviations of triplicate assays from 3 independent experiments, with unspliced
viral mRNA levels expressed relative to total viral mRNA levels. Significant differences between data were determined using Welch’s t-test against a
two-tailed distribution, the p values from which are indicated.
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we used a proteomics-based approach and identified 46
host proteins that co-immunoprecipitated with Nullbasic.
Many of the identified proteins can regulate Rev function.
For instance, B23 and CRM1 have been previously re-
ported to regulate Rev RNP nucleocytoplasmic transport
[4,10] and our previous studies demonstrated that Nullba-
sic has the capacity to alter the subcellular localizations of
B23 and CRM1 in a HIV-1 Rev-dependent manner [37]. In
addition to DDX1, DDX3 and DDX17, we also identified
DEAH (Asp - Glu - Ala - His)-box helicase 9 (DHX9) as a
Nullbasic-interacting protein that has been reported to
interact with HIV-1 Rev and mediate Rev RNP com-
plex transport [34,48]. In addition, Matrin 3 and serine/
arginine-rich splicing factor 1 (also called ASF/SF2) were
previously shown to regulate Rev function. Matrin 3 acts
as a cofactor of Rev that binds viral mRNA to form part
of the Rev RNP complex and in order to promote the nu-
clear export and translation of incompletely spliced viral
transcript [49-52]. ASF/SF2 is a sequence specific spli-
cing factor involved in pre-mRNA splicing [53]. In order
to balance spliced and unspliced forms of HIV-1 tran-
scripts, ASF/SF2 is recruited to the Rev RNP complex
and regulates HIV-1 mRNA splicing [54,55]. Our previ-
ous study indicated that Nullbasic could reduce steady
state levels of incompletely spliced viral mRNA [35], sug-
gesting that Nullbasic may play an inhibitory role in Rev-
mediated mRNA splicing or mRNA transport. In this
study, we use a Rev-dependent reporter, pGag-RRE, to
investigate the roles of identified DEAD-box RNA heli-
cases in Rev function (Figure 3). Because this reporter
only contains a 5′splice donor site without a splice ac-
ceptor site, transcripts produced from the reporter will
accumulate in the nucleus and are efficiently exported tothe cytoplasm for gene expression only in the presence of
Rev [27]. Our Rev reporter results demonstrated that
Nullbasic significantly reduced Rev-dependent reporter
gene expression (Figure 3), suggesting that Nullbasic in-
hibits Rev-mediated mRNA transport function leading to
reduced levels of unspliced transcripts, resulting in loss
of gene expression. However, we cannot exclude the pos-
sibility that Nullbasic also affects HIV-1 mRNA splicing
by, for example, interfering with ASF/SF2 function.
The expression level of DDX1 in cells has been shown
to highly regulate HIV-1 Rev’s subcellular distribution.
In the HeLa, Cos-1 and 293 T cell lines, HIV-1 Rev pre-
dominantly localizes in the nucleolus but also to the nu-
cleoplasm to a lesser extent [26,28,33,35,37]. Whereas
when DDX1 is expressed at lower levels, for instance in
human astrocytes and DDX1-downregulated cells, Rev
subcellular distribution is altered the nucleus to cyto-
plasm [26,28]. Thus DDX1 has been suggested to be re-
quired for proper subcellular localization of HIV-1 Rev.
By combining our results and above findings, we propose
a potential mechanism for the effects of Nullbasic on
HIV-1 Rev transport. In order to traffic Rev between the
nucleus and cytoplasm, Rev forms protein complexes with
different cellular proteins. In the absence of the RRE, Rev,
DDX1, B23 and other cellular proteins form a nuclear
complex. Our study provides further evidence that a major
role for DDX1 is to maintain the stability of this nuclear
complex and to thereby ensure Rev’s proper localization.
Within cells where Nullbasic is overexpressed, a DDX1
interaction with Nullbasic can modestly shift DDX1 sub-
cellular localization (Figure 4). Our results can be de-
scribed by a model where Nullbasic competes with Rev for
association with DDX1 although alternative explains are
possible. For example, the Nullbasic:DDX1 complex may
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Rev nuclear localization. Our study found Nullbasic inter-
action with DDX1 was Rev-independent and sufficient to
dysregulate the subcellular localization of Rev leading to
its accumulation in the cytoplasm so that Rev is observed
in the cytoplasm and nucleus. When Nullbasic and ex-
ogenous DDX1were co-expressed in cells, excessive DDX1
overcame Nullbasic’s inhibitory effect on Rev trafficking
thereby stabilizing Rev nuclear localization and func-
tion, despite nucleolar localization not being completely
restored.
Comparison of Tat and Rev cellular interacting part-
ners using the HIV-1, Human Protein Interaction Data-
base (http://www.ncbi.nlm.nih.gov/RefSeq/HIVInteractions)
revealed that many host cell proteins interact with both
viral proteins. Moreover, Gautier et al. [56] and Naji et al.
[34] used recombinant GST-Tat and MBP-Rev fusion
proteins to investigate the in vitro host cell interactome
of Tat and of Rev, respectively. Gautier et al. identified
183 potential Tat binding partners, of which DDX3,
DDX5, RHA, B23, matrin 3, CRM1, eEF1, HNRNPF,
HNRNPM, importin α, importin β, adenosine deami-
nase (ADAR) and poly(A) binding protein (PABPC1)
were also detected in Naji’s Rev study. Most of the pro-
teins commonly identified in both studies are essential
for the formation of the HIV-1 Rev RNP complex and
were also identified in our study. The function of HIV-1
Tat in the nucleolus remains uncertain. Using quantita-
tive proteomics, a study from Jarboui et al. [57] reported
that the composition of the nucleolus is changed in cells
expressing HIV-1 Tat, indicating that Tat may contribute
to creating a cellular environment in the nucleolus suit-
able for HIV-1 replication. Moreover, we also found that
Tat could associate with DDX1 in cells (Figure 7B), and
overexpression of wild type Tat could restore Rev activity
in cells co-expressing Nullbasic and HIV-1 (Figure 8).
One possibility is that Nullbasic is actually acting as a
type of transdominant negative protein, implying that
wild type Tat plays an undiscovered role in supporting
Rev activity in the nucleus.
Conclusions
Taken together, our work supports the findings that DDX1
is important for proper HIV-1 Rev nuclear localization and
function. Nullbasic, a HIV-1 Tat transdominant mutant,
sequesters DDX1 in cells resulting in disruption of Rev
subcellular distribution and function.
Methods
Plasmid constructs
pCMVΔR8.91 was a gift from Andreas Suhribier, QIMR
Berghofer Medical Research Institute, Australia and
pCMV-VSV-G was from Ian Mackay, The University
of Queensland, Australia. A plasmid expressing theBRU clone of HIV-1 Rev (pRSV-Rev) was a gift from
Damian Purcell, The University of Melbourne, Australia.
pcDNA3-HA, pcDNA3-HA-DDX1, pcDNA3-HA-DDX3
and pcDNA3-HA-DDX17 were obtained from Yasuo
Ariumi, Kumamoto University, Japan [33]. pGag-RRE and
pGag-CTE were obtained from Hans-Georg Krausslich.
The pcDNA3.1-Tat-FLAG plasmid was a gift from Monsef
Benkirane, Institute de Génétique Humaine, France. The
luciferase expression plasmid, pRL-SV40, was obtained
from Addgene (plasmid #27163). The construction of the
pcDNA 3.1-Nullbasic-FLAG, pcDNA 3.1-Nullbasic-FLAG-
mCherry (termed Nullbasic-mCherry) pcDNA 3.1-Rev
and pGCH plasmids have been described previously
[35,37]. pLOX-CW-FLAG-mCherry and pLOX-CW-
Nullbasic-mCherry expression plasmids were generated by
inverse PCR of FLAG-mCherry and Nullbasic-mCherry
form pcDNA 3.1-Nullbasic-mCherry, which were then
inserted into the pLOX-CW-eGFP plasmid (obtained from
Addgene, plasmid #12241) via Bam HI and Sal I restriction
sites. The primers used to generate FLAG-mCherry were
as follows: Forward (Fwd) 5′-AAA AGG ATC CCC ACC
ATG GAC TAC AAG GAC GA-3′ and Reverse (Rev) 5′-
TAT GAG TCG ACG TCG CGG CCG CTT TAC-3′. The
primers used to generate Nullbasic-mCherry were as
follows: Fwd 5′-ACT TAG GAT CCC CAC CAT
GGA GC-3′ and Rev 5′-TAT GAG TCG ACG TCG
CGG CCG CTT TAC-3′.
Cell lines and lentivirus particle production
HEK293T and HeLa cells were cultured in Dulbecco’s
Modified Eagle medium (DMEM) (Life Technologies)
supplemented with 10% (v/v) fetal bovine serum (Life
Technologies) and 1% (v/v) penicillin-streptomycin. All
cells were typically incubated at 37°C in a humidified 5%
CO2 atmosphere.
5 × 106 HEK293T cells were cultured in 10-cm dish
and co-transfected with 6 μg of pCMVΔR8.91 plasmid,
2 μg of pCMV-VSV-G and 2 μg of pLOX/CW-Nullbasic-
mCherry or pLOX/CW-FLAG-mCherry using the stand-
ard calcium phosphate transfection method. At 48 h
post-transfection, cell culture supernatants containing lenti-
virus particles were harvested, filtered through 0.45 μm fil-
ters and stored in small aliquots at −80°C until needed. The
amount of virus in the supernatants was determined using
the RETROtek HIV-1 p24 antigen enzyme-linked immuno-
sorbent assay (ELISA) kit (Zeptometrix Corporation) ac-
cording to the manufacturers’ instructions.
Co-immunoprecipitation assays
2.5 × 106 HEK293T cells grown in 10 cm2 dishes for
24 h and were transfected with of Tat-FLAG (2 μg),
Nullbasic-FLAG (2 μg), Rev (2 μg) or cotransfected with
Nullbasic-FLAG (2 μg) and Rev (2 μg) using X-tremeGENE
HP DNA transfection reagent (Roche) according to the
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cells were washed once with PBS, trypsinized and har-
vested by centrifugation for 5 min at 200 × g. The
supernatant was discarded and the pellet was lysed at
4°C for 30 min with lysis buffer (50 mM Tris–HCl,
pH 7.4; 150 mM NaCl; 1 mM EDTA; 0.5% [v/v] Triton
X-100; protease inhibitor cocktail [Roche]). The lysates
were cleared by centrifugation at 4°C and 12,000 × g for
10 min. FLAG-tagged proteins and interacting proteins
were captured using anti-FLAG M2 magnetic beads
(Sigma-Aldrich) as recommended by manufacture and
eluted with SDS-PAGE sample buffer (125 mM Tris–HCl,
pH 6.8; 4% [v/v] sodium dodecylsulfate (SDS); 20% [v/v]
glycerol; 0.004% [w/v] bromphenol blue). Protein lysates
were also immunoprecipitated with mouse DDX1 primary
antibody (Santa Cruz) conjugated to protein G magnetic
beads (Sigma-Aldrich) as recommended by manufacture
and eluted with SDS-PAGE sample buffer. The eluted pro-
tein complexes were analysed by Western blot using anti-
bodies as described.
Western blot analyses
Cell lysate were boiled in SDS-PAGE sample buffer and
separated by 12% sodium dodecylsulfate – polyacrylamide
gel electrophoresis (SDS-PAGE). Gels were electro-
blotted onto a polyvinylidene fluoride (PVDF) mem-
brane (Pall) using a semi-dry transfer system (Bio-Rad
Laboratories). Nullbasic-FLAG and Tat-FLAG proteins
were detected with a rabbit anti-DYKDDDDK Tag poly-
clonal antibody (Cell Signaling Technology). Rev was
detected with a mouse anti-Rev monoclonal antibody
(Santa Cruz Biotechnology). Endogenous CDK9, β-actin,
PARP, DDX1, DDX3 and DDX17 were detected with a
rabbit anti-CDK9 monoclonal antibody (Cell Signaling
Technology), mouse anti-β-actin monoclonal antibody
(Sigma Aldrich), mouse anti-PARP monoclonal anti-
body (Biolegend), rabbit anti-DDX1 polyclonal anti-
body (Abcam), rabbit anti-DDX3 polyclonal antibody
(Cell Signaling Technology)) and mouse anti-DDX17
monoclonal antibody (Santa Cruz Biotechnology). Pri-
mary antibodies were detected with HRP-conjugated
goat anti-rabbit or horse anti-mouse antibodies (Cell
Signaling Technology).
Immunofluorescence analyses and quantification of
Fn/c ratios
HeLa cells were grown on glass coverslips, seeded in
6-well plates (2 × 105 cells/well) and transfected were
transfected with Rev (1 μg) alone, NB-mcherry alone
(1 μg) or cotransfected Rev (1 μg) with NB-mcherry
(1 μg) using X-tremeGENE HP DNA transfection re-
agent according to the manufacturers’ instructions. For
DDX1 overexpression experiments, HeLa cells were grown
on glass coverslips and transfected with HA-DDX1(2 μg) alone, Rev (1 μg) with HA-DDX1 (2 μg), NB-
mCherry (1 μg) with HA-DDX1 (2 μg) or Rev (1 μg)
with NB-mCherry (1 μg) and HA-DDX1 (2 μg) using
X-tremeGENE HP DNA transfection reagent.
After 24 h transfection, cells were fixed in 3% (w/v)
paraformaldehyde at room temperature for 10 min and
quenched with 50 mM NH4Cl for 5 min. Cells were then
permeabilized with 0.1% (v/v) Triton X-100 for 15 min
and blocked in 10% (v/v) normal goat serum (Sapphire
Bioscience) for 15 min. Endogenous DDX1 protein
was detected with a rabbit anti-DDX1 polyclonal anti-
body. HA-DDX1 protein was detected with rabbit
anti-HA monoclonal antibody. MYC-Rev was probed with
mouse anti-MYC monoclonal antibody (Cell Signaling
Technology). Primary antibodies were detected with FITC-
conjugated goat anti-rabbit antibodies (Life Technologies)
and Cy5-conjugated goat anti-mouse antibodies (Life
Technologies). Nuclei were stained with 1 μM 4′,6-
diamidino-2-phenylindole (DAPI, Life Technologies). Fi-
nally, coverslips were mounted onto slides with ProLong
Gold antifade reagent (Life Technologies). Fluorescent im-
ages were captured using a Leica TCS SP2 confocal scan-
ning microscope (Leica Microsystems) with 63 × objective
lenses and standard lasers and filters for FITC, mCherry,
Cy5 and DAPI fluorescence. Confocal images were ana-
lyzed using the imageJ software 1.48 (http://imagej.nih.
gov/ij/) to quantify the fluorescence of nuclear (Fn) and
cytoplasmic (Fc). The nuclear/cytoplasm fluorescence ratio
(Fn/c) was calculated using the formula, Fn/c = (Fn – Fb) /
(Fc – Fb), where Fb is the background fluorescence.
Rev reporter assays
6 × 105 HEK293T cells were transfected with appropriate
expression vectors using X-tremeGENE HP DNA trans-
fection reagent according to the manufacturers’ instruc-
tions. To monitor plasmid transfection efficiency, a
luciferase reporter plasmid was included in each transfec-
tion. After 24 h transfection, the cells were washed with
PBS, trypsinized and harvested by centrifugation for 5 min
at 200 × g. The pelleted cells were then lysed at 4°C for
30 min with lysis buffer (50 mM Tris–HCl, pH 7.4;
150 mM NaCl; 1 mM EDTA; 1% [v/v] Triton X-100; prote-
ase inhibitor cocktail [Roche]). Cell lysates were centri-
fuged at 12,000 × g for 10 min and clarified supernatants
were collected. The amount of p24 was measured by
RETROtek HIV-1 p24 antigen ELISA kit according to
the manufacturers’ instructions and the transfection
efficiencies were assayed by BioLux luciferase assay
kit (New England BioLabs) according to the manufac-
turers’ instructions.
RNA splicing assay
HEK293T cells were transfected with 0.1 μg of pGCH
provirus along with 0.2 μg of either Tat-FLAG or
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tracted 24 h post-transfection using TRIzol reagent
(Invitrogen) and further isolated using the PolyAtract
mRNA isolation system (Promega). The purified total
RNA was reverse transcribed to cDNA using random hex-
amer primers and M-MuLV RT (New England BioLabs)
according to the manufacturer’s instructions. Viral cDNAs
were quantified by quantitative PCR using Platinum SYBR
Green Supermix (Invitrogen) on the Rotor-Gene Q
(Qiagen). The primers used to detect total and unspliced
viral mRNA has been described previously [58]. Reverse-
transcribed GAPDH cDNA was used to normalize extrac-
tion efficiency.
Recombinant proteins
Recombinant DDX1 and DDX3 proteins were pur-
chased from OriGene. The recombinant Nullbasic-
FLAG-V5-6xHis was produced in E. coli strain BL21-AI
(Invitrogen) transformed by pDEST42-Nullbasic-FLAG. A
200 ml culture was grown in Luria broth to log phase and
induced with 0.2% arabinose and 1 mM IPTG. After
4 hours the E. coli was collected by centrifugation and im-
mediately processed. 1× FastBreak™ Cell Lysis Reagent
(Promega) was added to the cell pellet for 15 min and the
lysate was mixed with 2 ml of Chelating Sepharose beads
(GE Healthsciences) for 1 min. The beads were placed into
a column and wash buffer (100 mM HEPES pH7.5,
10 mM imidazole) was applied 6 times. Two ml of elution
buffer (100 mM HEPES pH7.5, 500 mM imidazole) was
added and after 1 min was collected. The eluted protein
was dialysed twice for 90 minutes each in 1 liter of stor-
age buffer (20% glycerol v/v, 50 mM Tris–HCl pH8.0,
1 mM ZnCl2, adding fresh 2 mM 1,4-Dithioerythritol
every 30 minutes). The protein was stored in aliquots
under liquid nitrogen.
Bio-Layer interferometry assay
Interaction assays were performed in black 96 well mi-
croplates (Greiner Nio-one) at 25°C using Octet RED96
instrument (ForteBio). The recombinant Nullbasic pro-
teins were biotinylated using EZ-Link Sulfo-NHS-Biotin
(Pierce Biotechnology) following the manufacturer’s
instruction. Biotinylated Nullbasic proteins (1 μM) were
loaded onto Streptavidin biosensors (ForteBio) for 15 min
in 1× kinetics buffer (1 mM phosphate, 150 mM Nacl,
0.002% Tween-20 and 0.1 mg/ml BSA). Load biosensors
were then washed in 1× kinetics buffer at a shake speed of
1000 rpm for 5 min. Association was monitored by trans-
ferring ligand biosensors to wells containing recombinant
DDX1 or DDX3 with concentrations of 3.3 to 90 nM in
1× kinetics buffer at a shake speed of 1000 rpm for 15 min
followed by disassociation in 1× kinetics buffer at a shake
speed of 1000 rpm for 15 min. Data were processed using
Octet data analysis software 7.0 (ForteBio). Interactionanalysis between Nullbasic and BSA was also included as
a negative control.
Generation of HeLa-based cell line stably expressing
FLAG-mCherry and Nullbasic-mCherry
HeLa cells were transduced with 200 ng CAp24 of lenti-
virus prepared as described above. After 24 h trans-
duction, cells were washed, replaced with new culture
medium and further incubated for 48 h. At 72 h post-
transduction, cells were trypsinized, filtered through 37 μm
Nylon Mesh to remove cellular clumps and diluted in PBS
to a concentration of 2 × 107 cells/ml. Fluorescence-
activated cell sorting (FACS) analyses were performed
to isolate cells expressing high levels of mCherry using
a MoFlo high speed cell sorter (Beckman Coulter).
The isolated HeLa cells expressing Nullbasic-mCherry
(Hela-Nullbasic-mCherry) or FLAG-mCherry (Hela-FLAG-
mCherry) were expended and prepared for proteomic
experiments.
Preparation of nuclear extracts
Preparation of nuclear extracts from Hela cells was per-
formed as described previously [59,60]. Briefly, 1.8 × 107
Hela-Nullbasic-mCherry and Hela-FLAG-mCherry cells
were trypsinized and harvested by centrifugation for
10 min at 1850 × g. The pelleted cells were resuspended
in five volumes of 4°C PBS and collected by centrifu-
gation for 10 min at 1850 × g. The pelleted cells were
resuspended in five packed cell volumes (pcv) of hypo-
tonic buffer (10 mM HEPES, pH 7.9; 1.5 mM MgCl2;
10 mM KCl; 0.5 M DTT; protease inhibitor cocktail)
and collected by centrifugation. The packed cells were
resuspended in three pcv of hypotonic buffer and
allowed to swell for 10 min. The cells were transferred
to a glass Dounce homogenizer tube and lysed by 10 up-
and-down strokes using a clearance pestle. The hom-
ogenate was transferred to a new centrifuge tube and
centrifuged for 15 min at 3300 × g. The pellet obtained
from the centrifugation of the homogenate was subjected
to a second centrifugation for 20 min at 25,000 × g to re-
move residual cytoplasmic material and this pellet was
designated as crude nuclei. The crude nuclei were resus-
pended in one packed nuclear volume (pnv) of low salt
buffer (20 mM HEPES, pH 7.9; 25% (v/v) glycerol;
1.5 mM MgCl2; 0.2 mM EDTA; 0.5 M DTT; protease
inhibitor cocktail) and transferred to a glass Dounce
homogenizer tube. The nuclei were stroked gently using
a type B pestle. While stocking, 5 M KCl was added to
the resuspended nuclei drop wise to make the final con-
centration 0.42 M. The extract was transferred to a
capped tube and mixed gently on a rotating platform for
30 min at 4°C. The nuclear extract collected by ultracen-
trifugation for 1 h at 100,000 × g using Beckman Coulter
SW41T1 rotor and stored at −80°C. The total protein
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the Bradford method [61] against a bovine serum albu-
min standard.
In-gel tryptic digestion
FLAG-tagged proteins and interacting proteins from nu-
clear extracts were precipitated 2 h at 4°C with 40 μl of
Anti-FLAG Beads (Clontech). Immunoprecipitates were
spun down at 5000 × g for 1 min, washed three times
with wash buffer (50 mM Tris–HCl, pH 7.4; 150 mM
NaCl; 1 mM EDTA; protease inhibitor cocktail) and
eluted by competition with 200 μg/ml of FLAG pep-
tide (Sigma-Aldrich) overnight at 4°C. Following co-
immunoprecipitation assays, protein lysates were boiled
in SDS-PAGE sample buffer and separated by 12% SDS-
PAGE. Gels were stained in Bio-Safe Coomassie stain
(Bio-Rad) for 2 h and then washed in H2O overnight.
Protein bands were observed and images were gener-
ated by a LAS500 imaging system (Fujifilm Life Science).
Protein bands of interest were excized and cut into
1 × 1 mm pieces for analysis. Gel pieces were destained
in 200 μl of destaining buffer (50% [v/v] CH3CN;
200 mM NH4HCO3) for 90 min and dried with 200 μl of
100% (v/v) CH3CN for 10 min. Dried gel pieces were
rehydrated with 40 μl of trypsin solution (10% [v/v]
CH3CN; 40 mM NH4HCO3; 20 ng/μl Trypsin [Promega])
at 37°C for 1 h. Addition 50 μl of rehydration solution
(10% [v/v] CH3CN; 40 mM NH4HCO3) were added and
incubated at 37°C overnight. Following incubation, gel
pieces were microwaved on a low heat setting for 1 min
and peptides were collected into clean 1.5 ml tubes.
100 μl of 5% (v/v) formic acid was added to the gel
pieces, which were incubated for 20 min and sonicated
three times for 15 sec. Peptides were collected and
pooled with those collected previously. Next, 100 μl of
formic acid/acetonitrile solution (1% [v/v] formic acid;
60% [v/v] CH3CN) was added, and the gel pieces incu-
bated for 5 min and sonicated 3 times for 15 sec. Peptides
were collected and pooled with those collected previ-
ously. The pooled peptides were dried in the miVac con-
centrator (Genevac) and stored at −80°C until required.
Before analysis by mass spectrometry, dried peptides
were resuspended in 25 μl of 1% formic acid.
Protein identification by mass spectrometry
Following in-gel tryptic digestion, samples were analysed
by LC-MS/MS on a Nano HPLC (Shimadzu) coupled to
a QStar Elite mass spectrometer (AB SCIEX) with a
nano-electrospray ion source. Before sample injection,
50 mm × 300 mm C18 trap columns (Agilent) were
equilibrated with 1% Solvent B (90% [v/v] CH3CN; 0.1%
[v/v] formic acid). 8 μl of each extract was injected into
an equilibrated C18 trap column at 30 μl/min flow rate.
Samples were desalted on the column for 6 min andthen aligned with the nano HPLC 150 mm x 300 mm
C18 column (Vydac) for mass spectrometry analysis.
Peptides were eluted from the column with a linear gra-
dient of 1% to 40% solvent B over 25 min at 3 μl/min
flow rate, followed by a steeper gradient from 40% to
80% solvent B over 5 min were used for peptide elution.
Mass spectrometry was performed with ion spray volt-
age set to 3000 V, curtain gas flow 16, nebuliser gas 1
(GS1) and interface heater at 120°C. The mass spectrom-
eter acquired full scan of TOF-MS data followed by a
full scan product ion data in an information dependent
acquisition mode. Full scan TOF-MS data was acquired
over a mass range of 350 – 1800 and 100 – 1800 for
product ion ms/ms. Ions observed in the TOF-MS scan
exceeding a threshold of 12 counts and a charge state
of +2 to +5 were set to trigger the acquisition of product
ion, MS/MS spectra of the resultant 3 most intense ions.
The data was acquired and processed using Analyst® QS
2.0 software (ABSCIEX).Additional files
Additional file 1: The purity of nuclear factions. Fractionated protein
extracts were suggested to western blot analysis for determination of the
purity of nuclear and cytoplasmic fractions. Antibodies detecting β-actin,
poly(ADP-ribose) polymerase (PARP) and FLAG were used.
Additional file 2: Forty-six proteins consistently detected in nuclear
fractions. Proteins present in Nullbasic-expressed nuclear fraction were
identified by mass spectrometry. Proteins were considered “identified” if
two or more peptides with > 95% confidence were detected. The identified
proteins were grouped by protein function.
Additional file 3: Nullbasic does not affect the DDX3 and DDX17
subcellular distributions. HeLa cells were transfected to express empty
vector alone (pcDNA3.1, row 1 and 3), MYC-Rev alone (row 2 and 6),
Nullbasic (NB)-mCherry alone (row 3 and 7) or MYC-Rev with NB-mCherry
(row 4 and 8). Fixed cells were immunostained anti-MYC antibodies (green)
with anti-DDX3 or DDX17 antibodies (magenta) before the subcellular
localization of MYC-Rev, NB-mCherry (red), endogenous DDX3 and DDX17
were visualized by fluorescence microscopy. Nuclei were stained with DAPI.
Images are representative of at least five fields selected randomly from three
independent experiments.
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